RNA-omics for improved cancer therapy decision support
Fri
15
Sep
Friday 15 September, 2023at 12:15 - 13:00
Zoom
RNA omics data is vastily available but rarely used for clinical decision support. We have buildt classifiers for clinically relevant features using Machine Learning and use them to characterize samples based on their gene expression data and provide the information in report for doctors who can use the information for improved knowledge-based therapeutic decisions
Björn Rotter studied Bology in Germany, USA and France, PhD in Biochemistry in Paris, started GenXPro in 2005 together with former colleagues in Frankfurt am Main, since 2021 CEO of GenXPro